Modulating E2 enzyme activity can have therapeutic potential for various diseases. Small molecule inhibitors, peptides, and other compounds can be designed to target specific E2 enzymes, inhibiting or enhancing their activity. Such interventions could help restore normal protein degradation processes in diseases characterized by proteostasis imbalance.
